ipamorelin + cjc-1295 blend cjc Blend: Ipamorelin (No DAC) 20MG CJC-1295 + Ipamorelin Blend 10mg

Protects and strengthens bone, increasing bone formation and mineral density

TB-500: not FDA-approved

2014 (Int J Colorectal Dis) Type Phase II Subjects 117 bowel surgery patients (NCT00672074) Key Finding Ipamorelin 0.03 mg/kg IV twice daily was tolerated similarly to placebo

This personalised approach ensures optimal results while minimising potential side effects, like tooth sensitivity

Metabolic & Body Composition Consultation $100 We start with a focused visit where we review: Your weight and diet history , past attempts, and current challenges Symptoms like cravings, low energy, or emotional eating Any known metabolic conditions (e.g., insulin resistance, high A1c) Your activity level, sleep, stress, and daily routine Full medical history and medication list This helps us determine if Tirzepatide plus CJC1295/Ipamorelin is appropriateor if another approach, or a stepwise plan, would better match your needs and safety profile